Raymond James Reiterates Outperform on CME Group, Maintains $320 Price Target

CME Group Inc. Class A

CME Group Inc. Class A

CME

0.00

Raymond James analyst Patrick O'Shaughnessy reiterates CME Group (NASDAQ: CME) with a Outperform and maintains $320 price target.